BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 17370640)

  • 1. [Regulation of telomerase and its clinical application in blood cells].
    Yamada O
    Rinsho Ketsueki; 2007 Feb; 48(2):117-33. PubMed ID: 17370640
    [No Abstract]   [Full Text] [Related]  

  • 2. Telomeres and telomerase in hematologic neoplasia.
    Ohyashiki JH; Sashida G; Tauchi T; Ohyashiki K
    Oncogene; 2002 Jan; 21(4):680-7. PubMed ID: 11850796
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Concise review: Telomere biology in normal and leukemic hematopoietic stem cells.
    Drummond MW; Balabanov S; Holyoake TL; Brummendorf TH
    Stem Cells; 2007 Aug; 25(8):1853-61. PubMed ID: 17510216
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Telomere maintenance and cancer -- look, no telomerase.
    Neumann AA; Reddel RR
    Nat Rev Cancer; 2002 Nov; 2(11):879-84. PubMed ID: 12415258
    [No Abstract]   [Full Text] [Related]  

  • 5. Telomerase as a target for cancer therapy.
    Parkinson KE
    Curr Opin Investig Drugs; 2005 Jun; 6(6):605-10. PubMed ID: 15988912
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Telomeres and telomerase as targets for anticancer drug development.
    Olaussen KA; Dubrana K; Domont J; Spano JP; Sabatier L; Soria JC
    Crit Rev Oncol Hematol; 2006 Mar; 57(3):191-214. PubMed ID: 16469501
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmacological intervention strategies for affecting telomerase activity: future prospects to treat cancer and degenerative disease.
    Tárkányi I; Aradi J
    Biochimie; 2008 Jan; 90(1):156-72. PubMed ID: 17945408
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Telomeres, senescence, and hematopoietic stem cells.
    Zimmermann S; Martens UM
    Cell Tissue Res; 2008 Jan; 331(1):79-90. PubMed ID: 17960423
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Telomerase as a therapeutic target. Therapeutic potential of telomerase inhibitors.
    Double JA
    Methods Mol Biol; 2002; 191():209-16. PubMed ID: 11951608
    [No Abstract]   [Full Text] [Related]  

  • 10. New targets for cancer chemotherapy.
    Murgo AJ; Dancey J; Eckhardt SG; Hidalgo M; Arbuck SG; Zerivitz K; Blaylock BA
    Cancer Chemother Biol Response Modif; 2002; 20():239-72. PubMed ID: 12703208
    [No Abstract]   [Full Text] [Related]  

  • 11. Regulation mechanisms of mammalian telomerase. A review.
    Ishikawa F
    Biochemistry (Mosc); 1997 Nov; 62(11):1332-7. PubMed ID: 9467858
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Consequences of telomerase inhibition by BIBR1532 on proliferation and chemosensitivity of chondrosarcoma cell lines.
    Parsch D; Brassat U; Brümmendorf TH; Fellenberg J
    Cancer Invest; 2008 Jul; 26(6):590-6. PubMed ID: 18584350
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Targeting telomeres and telomerase.
    De Cian A; Lacroix L; Douarre C; Temime-Smaali N; Trentesaux C; Riou JF; Mergny JL
    Biochimie; 2008 Jan; 90(1):131-55. PubMed ID: 17822826
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Telomere biology of pediatric cancer.
    Tabori U; Dome JS
    Cancer Invest; 2007; 25(3):197-208. PubMed ID: 17530490
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Telomere biology of human hematopoietic stem cells.
    Elwood N
    Cancer Control; 2004; 11(2):77-85. PubMed ID: 15024344
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Reversal of hepatoma cells resistance to anticancer drugs is correlated to cell proliferation kinetics, telomere length and telomerase activity.
    Chau NP; Deschatrette J; Wolfrom C
    Anticancer Res; 2005; 25(5):3279-85. PubMed ID: 16101139
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Establishment of immortalized multipotent hematopoietic progenitor cell lines by retroviral-mediated gene transfer of beta-catenin.
    Templin C; Kotlarz D; Rathinam C; Rudolph C; Schätzlein S; Ramireddy K; Rudolph KL; Schlegelberger B; Klein C; Drexler H
    Exp Hematol; 2008 Feb; 36(2):204-15. PubMed ID: 18206728
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Boning up on telomerase.
    Tuan R
    Nat Biotechnol; 2002 Jun; 20(6):560-1. PubMed ID: 12042856
    [No Abstract]   [Full Text] [Related]  

  • 19. [Telomere and telomerase as starting-points of new forms of treatment in oncology].
    Martens UM; Waller CF
    Dtsch Med Wochenschr; 2001 Oct; 126(42):1171-2. PubMed ID: 11607857
    [No Abstract]   [Full Text] [Related]  

  • 20. [Telomere terminals and telomerase. The biological aging clock?].
    Kølvraa S; Bischoff C; Bohr VA
    Ugeskr Laeger; 1999 Jun; 161(26):3987-91. PubMed ID: 10402933
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.